Microvessel Density and Status of p53 Protein as Potential Prognostic Factors for Adjuvant Anthracycline Chemotherapy in Retrospective Analysis of Early Breast Cancer Patients Group

A considerable subgroup of patients with early breast cancer does not address benefits of anthracycline based chemotherapy. The aim of this retrospective study was to investigate the effect of microvessel density (MVD) and status of p53 protein on 5-year disease free survival (DFS) in the group of b...

Descripción completa

Detalles Bibliográficos
Autores principales: Biesaga, Beata, Niemiec, Joanna, Ziobro, Marek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448052/
https://www.ncbi.nlm.nih.gov/pubmed/22549273
http://dx.doi.org/10.1007/s12253-012-9525-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3448052/
https://www.ncbi.nlm.nih.gov/pubmed/22549273
http://dx.doi.org/10.1007/s12253-012-9525-9

Ejemplares similares